Quantum Blue Adalimumab Assay
Recall Summary The Quantum Blue Adalimumab Assay, a diagnostic test used to measure adalimumab levels in patients, is being recalled across Canada because the test kits are failing prematurely and may not work as intended. This is classified as a serious safety issue (Class I recall). The product was distributed throughout Canada.
- Product
- Quantum Blue Adalimumab Assay
- Reason
- Premature failure
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DEVICES
- Recall date
- 2021-12-08
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DEVICES
Recall details on Nibble Recalls: https://trynibble.app/recalls/ae6a1baf-9c86-4c93-81ac-0d9c89fabce1